BRIEF-Gemini reports Q1 net loss per share of $0.04
* Now expecting revenue for 2017 to be less than 2016 but expects activity to pick up in second half of 2017 into 2018 Source text for Eikon: Further company coverage:
TOKYO, Sept 3 The Tokyo Stock Exchange said on Thursday it suspended trade on Dainippon Sumitomo Pharma Co (4506.T) from 2320 GMT after a source with knowledge of the situation said the Japanese drugmaker plans to offer $2.7 billion for U.S. drugmaker Sepracor Inc SEPR.O [ID:nN02545273].
"We have no comment at this point," Dainippon Sumitomo Pharma said in a release.
(Reporting by Mayumi Negishi)
* Ironhorse announces Q1 2017 financial and operating results
* AT&T announces IBEW-represented employees vote to ratify midwest wireline agreement